Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Sarni

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Asian Journal of Psychiatry|October 18, 2025
The psychosis continuum: Systematic review on prodromal markers, symptom progression, and early intervention strategiesValerio Ricci, Alessandro Sarni, Giovanni Martinotti, et al.
Rivista Di Psichiatria|April 17, 2025
Lysergic psychoma and mental automatism: a clinical exploration of synthetic psychosisAlessandro Sarni, Giovanni Martinotti, Giuseppe Maina, et al.
International Clinical Psychopharmacology|June 28, 2024
Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative reviewValerio Ricci, Alessandro Sarni, Giovanni Martinotti, et al.
Journal of Mental Health (Abingdon, England)|May 21, 2026
Medication adherence, cannabis use, and depressive symptoms in first-episode psychosis: longitudinal studyValerio Ricci, Alessandro Sarni, Thomas Fraccalini, et al.
Asian Journal of Psychiatry|April 14, 2026
Multi-dimensional recovery trajectories in cannabis-induced psychosis: A systematic review examining symptomatic, functional, cognitive, and subjective outcomesValerio Ricci, Alessandro Sarni, Marialuigia Barresi, et al.
Healthcare (Basel, Switzerland)|August 14, 2025
Anhedonia and Negative Symptoms in First-Episode Psychosis: A Systematic Review and Meta-Analysis of Prevalence, Mechanisms, and Clinical ImplicationsValerio Ricci, Alessandro Sarni, Marialuigia Barresi, et al.
Journal of Psychopharmacology (Oxford, England)|December 2, 2025
The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applicationsValerio Ricci, Alessandro Sarni, Domenico De Berardis, et al.
Frontiers in Psychiatry|May 13, 2026
How adolescent cannabis use reshapes the developing brain - a systematic reviewValerio Ricci, Alessandro Sarni, Domenico De Berardis, et al.
Brain Sciences|June 26, 2026
Biomarkers for Predicting Clinical Deterioration in Schizophrenia-Spectrum Disorders: A Systematic ReviewValerio Ricci, Alessandro Sarni, Marialuigia Barresi, et al.
Asian Journal of Psychiatry|July 12, 2025
Cannabis and suicide risk in first-episode psychosis: Mechanisms, interactions, and intervention strategiesValerio Ricci, Alessandro Sarni, Marialuiga Barresi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Asian Journal of Psychiatry|October 18, 2025
The psychosis continuum: Systematic review on prodromal markers, symptom progression, and early intervention strategiesValerio Ricci, Alessandro Sarni, Giovanni Martinotti, et al.
Rivista Di Psichiatria|April 17, 2025
Lysergic psychoma and mental automatism: a clinical exploration of synthetic psychosisAlessandro Sarni, Giovanni Martinotti, Giuseppe Maina, et al.
International Clinical Psychopharmacology|June 28, 2024
Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative reviewValerio Ricci, Alessandro Sarni, Giovanni Martinotti, et al.
Journal of Mental Health (Abingdon, England)|May 21, 2026
Medication adherence, cannabis use, and depressive symptoms in first-episode psychosis: longitudinal studyValerio Ricci, Alessandro Sarni, Thomas Fraccalini, et al.
Asian Journal of Psychiatry|April 14, 2026
Multi-dimensional recovery trajectories in cannabis-induced psychosis: A systematic review examining symptomatic, functional, cognitive, and subjective outcomesValerio Ricci, Alessandro Sarni, Marialuigia Barresi, et al.
Healthcare (Basel, Switzerland)|August 14, 2025
Anhedonia and Negative Symptoms in First-Episode Psychosis: A Systematic Review and Meta-Analysis of Prevalence, Mechanisms, and Clinical ImplicationsValerio Ricci, Alessandro Sarni, Marialuigia Barresi, et al.
Journal of Psychopharmacology (Oxford, England)|December 2, 2025
The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applicationsValerio Ricci, Alessandro Sarni, Domenico De Berardis, et al.
Frontiers in Psychiatry|May 13, 2026
How adolescent cannabis use reshapes the developing brain - a systematic reviewValerio Ricci, Alessandro Sarni, Domenico De Berardis, et al.
Brain Sciences|June 26, 2026
Biomarkers for Predicting Clinical Deterioration in Schizophrenia-Spectrum Disorders: A Systematic ReviewValerio Ricci, Alessandro Sarni, Marialuigia Barresi, et al.
Asian Journal of Psychiatry|July 12, 2025
Cannabis and suicide risk in first-episode psychosis: Mechanisms, interactions, and intervention strategiesValerio Ricci, Alessandro Sarni, Marialuiga Barresi, et al.
Pageof 2